$577 Million is the total value of Parkman Healthcare Partners LLC's 95 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 45.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $27,147,394 | +12.2% | 122,978 | +13.8% | 4.71% | -10.6% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $25,590,249 | +19.4% | 473,105 | +10.5% | 4.44% | -4.8% |
SDGR | Buy | SCHRODINGER INC | $24,092,690 | +129.2% | 482,626 | +20.9% | 4.18% | +82.7% |
BDX | Buy | BECTON DICKINSON & CO | $22,083,380 | +124.2% | 83,646 | +110.2% | 3.83% | +78.7% |
THC | Buy | TENET HEALTHCARE CORP | $20,673,531 | +87.2% | 254,037 | +36.7% | 3.58% | +49.2% |
LNTH | Buy | LANTHEUS HLDGS INC | $20,606,304 | +33.3% | 245,547 | +31.2% | 3.57% | +6.3% |
PODD | Buy | INSULET CORP | $16,738,425 | +82.6% | 58,051 | +102.0% | 2.90% | +45.5% |
ABC | New | AMERISOURCEBERGEN CORP | $16,597,088 | – | 86,250 | +100.0% | 2.88% | – |
IMGN | New | IMMUNOGEN INC | $15,866,104 | – | 840,811 | +100.0% | 2.75% | – |
COO | Sell | COOPER COS INC | $15,384,362 | -21.3% | 40,123 | -23.4% | 2.67% | -37.3% |
DHR | Buy | DANAHER CORPORATION | $14,567,040 | +279.8% | 60,696 | +298.9% | 2.52% | +202.8% |
Buy | RXSIGHT INC | $14,360,573 | +101.3% | 498,631 | +16.6% | 2.49% | +60.4% | |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $13,177,011 | -40.2% | 139,735 | -35.9% | 2.28% | -52.4% |
PCVX | Buy | VAXCYTE INC | $11,411,540 | +63.6% | 228,505 | +22.8% | 1.98% | +30.4% |
KROS | Buy | KEROS THERAPEUTICS INC | $11,122,427 | +45.3% | 276,815 | +54.4% | 1.93% | +15.8% |
DXCM | Buy | DEXCOM INC | $10,939,542 | +19.3% | 85,126 | +7.9% | 1.90% | -4.9% |
WAT | Buy | WATERS CORP | $10,844,980 | +195.2% | 40,688 | +242.9% | 1.88% | +135.3% |
KRTX | Buy | KARUNA THERAPEUTICS INC | $10,676,176 | +49.5% | 49,233 | +25.3% | 1.85% | +19.2% |
SILK | Buy | SILK RD MED INC | $9,991,487 | +6.5% | 307,525 | +28.2% | 1.73% | -15.1% |
HAE | Sell | HAEMONETICS CORP MASS | $9,796,294 | -15.9% | 115,061 | -18.2% | 1.70% | -33.0% |
ANIP | Buy | ANI PHARMACEUTICALS INC | $9,392,097 | +136.5% | 174,477 | +74.5% | 1.63% | +88.4% |
VRNA | Sell | VERONA PHARMA PLCsponsored ads | $8,476,865 | -13.5% | 400,987 | -17.8% | 1.47% | -31.1% |
XENE | Sell | XENON PHARMACEUTICALS INC | $8,382,990 | -15.5% | 217,740 | -21.5% | 1.45% | -32.7% |
DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $8,071,205 | +6.2% | 573,239 | +16.6% | 1.40% | -15.3% |
MNKD | Buy | MANNKIND CORP | $7,393,485 | +22.3% | 1,816,581 | +23.2% | 1.28% | -2.4% |
XFOR | Buy | X4 PHARMACEUTICALS INC | $7,307,190 | +200.3% | 3,766,593 | +34.7% | 1.27% | +139.5% |
ETNB | Buy | 89BIO INC | $6,611,181 | +75.8% | 348,875 | +41.3% | 1.15% | +40.1% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $6,279,724 | +16.2% | 153,052 | +1.3% | 1.09% | -7.3% |
Buy | ARCELLX INC | $6,174,121 | +35.7% | 195,260 | +32.2% | 1.07% | +8.2% | |
CTLT | New | CATALENT INC | $6,124,600 | – | 141,250 | +100.0% | 1.06% | – |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $5,716,781 | +19.6% | 190,179 | +44.2% | 0.99% | -4.6% |
TGTX | Sell | TG THERAPEUTICS INC | $5,480,549 | +32.2% | 220,634 | -20.0% | 0.95% | +5.3% |
VCYT | Buy | VERACYTE INC | $5,398,621 | +104.1% | 211,960 | +78.7% | 0.94% | +62.8% |
STRO | Buy | SUTRO BIOPHARMA INC | $5,318,954 | +4.7% | 1,143,861 | +4.0% | 0.92% | -16.6% |
DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $5,113,651 | -4.4% | 428,279 | +7.0% | 0.89% | -23.9% |
HUM | Sell | HUMANA INC | $4,989,971 | -42.4% | 11,160 | -37.4% | 0.86% | -54.1% |
INSP | New | INSPIRE MED SYS INC | $4,697,541 | – | 14,470 | +100.0% | 0.81% | – |
BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $4,396,713 | +39.9% | 172,285 | +16.6% | 0.76% | +11.4% |
SNDX | New | SYNDAX PHARMACEUTICALS INC | $4,359,007 | – | 208,266 | +100.0% | 0.76% | – |
SGEN | Sell | SEAGEN INC | $4,349,981 | -70.6% | 22,602 | -69.1% | 0.75% | -76.6% |
PACB | New | PACIFIC BIOSCIENCES CALIF IN | $4,329,150 | – | 325,500 | +100.0% | 0.75% | – |
MMS | New | MAXIMUS INC | $4,257,698 | – | 50,381 | +100.0% | 0.74% | – |
IMVT | Buy | IMMUNOVANT INC | $4,113,986 | +42.6% | 216,868 | +16.6% | 0.71% | +13.5% |
KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $4,107,178 | +52.5% | 291,703 | +16.6% | 0.71% | +21.5% |
New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $4,080,000 | – | 80,000 | +100.0% | 0.71% | – | |
ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $3,985,075 | +135.3% | 58,083 | +132.3% | 0.69% | +87.8% |
PFMT | Sell | PERFORMANT FINL CORP | $3,905,321 | -26.1% | 1,446,415 | -6.9% | 0.68% | -41.1% |
NEO | New | NEOGENOMICS INC | $3,790,061 | – | 235,847 | +100.0% | 0.66% | – |
SIBN | New | SI-BONE INC | $3,747,927 | – | 138,915 | +100.0% | 0.65% | – |
CGEM | Buy | CULLINAN ONCOLOGY INC | $3,731,364 | +114.7% | 346,781 | +104.1% | 0.65% | +71.2% |
NTRA | Sell | NATERA INC | $3,651,398 | -47.4% | 75,039 | -40.0% | 0.63% | -58.1% |
EVH | Sell | EVOLENT HEALTH INCcl a | $3,620,608 | -40.3% | 119,492 | -36.1% | 0.63% | -52.4% |
EWTX | Buy | EDGEWISE THERAPEUTICS INC | $3,520,414 | +747.4% | 454,247 | +629.3% | 0.61% | +577.8% |
AKYA | Buy | AKOYA BIOSCIENCES INC | $3,480,690 | +111.3% | 471,000 | +133.9% | 0.60% | +68.4% |
SAGE | Buy | SAGE THERAPEUTICS INC | $3,292,952 | +209.9% | 70,033 | +176.6% | 0.57% | +147.2% |
KRMD | Buy | KORU MEDICAL SYSTEMS INC | $3,101,767 | -13.7% | 899,063 | +5.6% | 0.54% | -31.1% |
LXRX | Buy | LEXICON PHARMACEUTICALS INC | $3,047,111 | +85.7% | 1,330,616 | +97.0% | 0.53% | +47.9% |
IDYA | New | IDEAYA BIOSCIENCES INC | $2,992,467 | – | 127,339 | +100.0% | 0.52% | – |
ESPR | Buy | ESPERION THERAPEUTICS INC NE | $2,963,910 | -0.8% | 2,132,309 | +13.5% | 0.51% | -20.9% |
SWAV | Sell | SHOCKWAVE MED INC | $2,875,791 | -71.7% | 10,076 | -78.5% | 0.50% | -77.4% |
Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $2,842,316 | +86.4% | 239,051 | +107.9% | 0.49% | +48.5% | |
BDTX | New | BLACK DIAMOND THERAPEUTICS I | $2,525,000 | – | 500,000 | +100.0% | 0.44% | – |
LBPH | New | LONGBOARD PHARMACEUTICALS IN | $2,507,249 | – | 341,587 | +100.0% | 0.44% | – |
CDMO | Sell | AVID BIOSERVICES INC | $2,485,263 | -70.8% | 177,900 | -60.8% | 0.43% | -76.7% |
ARVN | New | ARVINAS INC | $2,482,000 | – | 100,000 | +100.0% | 0.43% | – |
LYRA | New | LYRA THERAPEUTICS INC | $2,466,000 | – | 600,000 | +100.0% | 0.43% | – |
RCUS | Buy | ARCUS BIOSCIENCES INC | $2,438,195 | +29.8% | 120,049 | +16.6% | 0.42% | +3.4% |
ACAD | New | ACADIA PHARMACEUTICALS INC | $2,395,000 | – | 100,000 | +100.0% | 0.42% | – |
AXGN | Buy | AXOGEN INC | $2,381,634 | +12.6% | 260,858 | +16.6% | 0.41% | -10.2% |
TVTX | Buy | TRAVERE THERAPEUTICS INC | $2,247,521 | -29.6% | 146,323 | +3.1% | 0.39% | -43.8% |
New | DISC MEDICINE INC | $2,220,000 | – | 50,000 | +100.0% | 0.38% | – | |
LQDA | Sell | LIQUIDIA CORPORATION | $2,206,902 | -2.3% | 281,134 | -14.0% | 0.38% | -22.0% |
COGT | Buy | COGENT BIOSCIENCES INC | $2,199,659 | +12.1% | 185,782 | +2.1% | 0.38% | -10.8% |
CVRX | New | CVRX INC | $2,173,381 | – | 140,763 | +100.0% | 0.38% | – |
CSTL | New | CASTLE BIOSCIENCES INC | $2,030,587 | – | 148,002 | +100.0% | 0.35% | – |
ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,007,601 | +49.5% | 193,597 | +16.6% | 0.35% | +19.2% |
Sell | MARINUS PHARMACEUTICALS INC | $1,857,875 | +7.7% | 171,075 | -31.6% | 0.32% | -14.1% | |
New | ASLAN PHARMACEUTICALS LTDspon ads new | $1,849,167 | – | 506,621 | +100.0% | 0.32% | – | |
MRUS | New | MERUS N V | $1,787,307 | – | 67,881 | +100.0% | 0.31% | – |
GRTX | Buy | GALERA THERAPEUTICS INC | $1,687,443 | +25.6% | 540,847 | +3.0% | 0.29% | +0.3% |
AKRO | New | AKERO THERAPEUTICS INC | $1,634,150 | – | 35,000 | +100.0% | 0.28% | – |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $1,614,547 | +8.2% | 62,410 | +0.5% | 0.28% | -13.8% |
TELA | Buy | TELA BIO INC | $1,610,933 | +10.2% | 159,026 | +15.8% | 0.28% | -12.3% |
IMUX | Buy | IMMUNIC INC | $1,354,780 | +97.8% | 539,753 | +17.4% | 0.24% | +57.7% |
QTRX | New | QUANTERIX CORP | $1,130,747 | – | 50,144 | +100.0% | 0.20% | – |
SLN | Buy | SILENCE THERAPEUTICS PLCads | $1,017,929 | +3.4% | 185,078 | +16.6% | 0.18% | -17.8% |
INZY | Buy | INOZYME PHARMA INC | $940,160 | +31.3% | 168,790 | +35.0% | 0.16% | +4.5% |
TERN | Buy | TERNS PHARMACEUTICALS INC | $896,219 | +0.9% | 102,425 | +36.6% | 0.16% | -19.7% |
NSTG | New | NANOSTRING TECHNOLOGIES INC | $759,375 | – | 187,500 | +100.0% | 0.13% | – |
AFIB | Buy | ACUTUS MED INC | $676,678 | +37.3% | 762,025 | +16.6% | 0.12% | +9.3% |
VYGR | New | VOYAGER THERAPEUTICS INC | $662,737 | – | 57,881 | +100.0% | 0.12% | – |
SVRA | Buy | SAVARA INC | $660,109 | +91.0% | 206,607 | +16.6% | 0.11% | +52.0% |
TKNO | Buy | ALPHA TEKNOVA INC | $470,758 | +5.1% | 176,314 | +16.6% | 0.08% | -15.5% |
Buy | MINERALYS THERAPEUTICS INC | $198,769 | +26.9% | 11,658 | +16.6% | 0.03% | 0.0% | |
CDTX | Sell | CIDARA THERAPEUTICS INC | $153,692 | -79.8% | 136,011 | -77.3% | 0.03% | -83.7% |
GRTS | Exit | GRITSTONE BIO INC | $0 | – | -151,921 | -100.0% | -0.09% | – |
Exit | AADI BIOSCIENCE INC | $0 | – | -75,961 | -100.0% | -0.12% | – | |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.36% | – |
Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -67,252 | -100.0% | -0.42% | – | |
LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -47,608 | -100.0% | -0.50% | – |
ISEE | Exit | IVERIC BIO INC | $0 | – | -97,082 | -100.0% | -0.51% | – |
BIIB | Exit | BIOGEN INC | $0 | – | -17,920 | -100.0% | -1.08% | – |
MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -25,840 | -100.0% | -1.36% | – |
CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -1,753,630 | -100.0% | -1.60% | – |
ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -65,000 | -100.0% | -1.83% | – |
IQV | Exit | IQVIA HLDGS INC | $0 | – | -45,643 | -100.0% | -1.97% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -27,671 | -100.0% | -2.07% | – |
ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -21,643 | -100.0% | -2.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEXCOM INC | 16 | Q3 2023 | 6.3% |
ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
NATERA INC | 16 | Q3 2023 | 3.4% |
AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
MANNKIND CORP | 15 | Q3 2023 | 1.6% |
IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.